Cellife NAD II

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

ferrous fumarate, Quantity: 25 mg (Equivalent: iron, Qty 8 mg); nicotinamide, Quantity: 10 mg; manganese amino acid chelate, Quantity: 35 mg (Equivalent: manganese, Qty 3.5 mg); cyanocobalamin, Quantity: 0.0024 mg; leucine, Quantity: 100 mg; heavy magnesium oxide, Quantity: 100 mg (Equivalent: magnesium, Qty 60 mg); nicotinic acid, Quantity: 100 mg; calcium gluconate monohydrate, Quantity: 225 mg (Equivalent: calcium, Qty 20 mg); quercetin, Quantity: 13 mg; menaquinone 7, Quantity: 0.06 mg; Cinnamomum cassia, Quantity: 50 mg (Equivalent: Cinnamomum cassia, Qty 500 mg; Equivalent: coumarin, Qty 0.001 mg); Reynoutria japonica, Quantity: 30 mg (Equivalent: Reynoutria japonica, Qty 300 mg); zinc glycinate, Quantity: 29 mg (Equivalent: zinc, Qty 8 mg)

Prieinama:

Cellife Health Products Pty Ltd

Vaisto forma:

Tablet, uncoated

Sudėtis:

Excipient Ingredients: microcrystalline cellulose; isomalt; magnesium stearate; colloidal anhydrous silica; mannitol

Vartojimo būdas:

Oral

Terapinės indikacijos:

Helps reduce/decrease free radical damage to body cells ; Helps improve/promote body metabolism/metabolic rate ; Maintain/support body tissue repair/regeneration

Produkto santrauka:

Visual Identification: ;

Autorizacija statusas:

Listed

Leidimo data:

2019-08-21